As a secretary of the Central Nervous System & Head and Neck Subspecialty Group, Department of Pathology, Sun Yat-sen University Cancer Center. He has published over 40 SCI papers as first/corresponding author (including co-authored), contributed to 4 Chinese-English academic monographs, secured funding as principal investigator for one National Natural Science Foundation of China Young Scientists Fund project and one Guangzhou Science and Technology Plan project, currently serves as Young Editorial Board Member of Chinese Journal of General Surgery, Academic Editor of BioMed Research International, and Database Judge Panel Member of the CSCIED Core Scientific Journal Evaluation Database.

Honors & Awards

· Dr. Liang Boqiang & Dr. Qin Guangyu Annual Pathology Award of Sun Yat-sen University (2015)

· Champion of the 3rd Guangdong Provincial Young Pathologists Diagnostic Competition (2020)

· The Top Prize for the Public Selection Group in the Thirteenth Teacher Teaching Competition of Sun Yat-sen University (2025)

Professional Affiliations
1.Chinese Anti-Cancer Association (CACA):
  Committee Member, Brain Glioma Professional Committee.
2.Chinese Medical Doctor Association:
  Committee Member, Molecular Subgroup of the 3rd Glioma Professional Committee.
3.Guangdong Anti-Cancer Association:
  Committee Member, Neuro-Oncology Professional Committee;
  Committee Member, Head and Neck Oncology Professional Committee;
  Youth Committee Member, Tumor Pathology Professional Committee.
4.Guangdong Clinical Medicine Association:
  Youth Committee Member, Pathology Professional Committee.
5.Guangdong Precision Medicine Application Association:
  Committee Member, Molecular Pathology Branch;
  Standing Committee Member, Head and Neck Oncology Branch.
6.Guangdong Health Management Association:
  Standing Committee Member, Multidisciplinary Diagnosis and Treatment Committee for Maxillofacial and Head-Neck Diseases.
7.Guangdong Primary Medicine Association:
  Vice Chairperson, Multidisciplinary Diagnosis and Treatment Committee for Brain Glioma.

Focusing on central nervous system tumors and head/neck tumors (pathological diagnosis, molecular subtyping, rare CNStumor diagnosis and therapeutic targets, immune microenvironment, AI pathology, etc.)

Doctor’s degree (Clinical pathology), Southern Medical University, Guangzhou, China, September 2017 to July 2020.

Master’s degree (Pathology and Pathophysiology), Xiangya School of Medicine, Central South University, Changsha, China, September 2010 to July 2013.

Bachelor’s degree (Clinical medicine), Changsha Medical University, China, September 2005 to July 2010.

1. Yanghao Hou, Yanru Du, Juan Wang, Xinke Zhang, Xueyan Zhao, Xinyi Xian, Li Yuan, Haigang Li, Yu Wang, Shaoyan Xi, Guan Huang, Wenbiao Zhu, Juan Wang, Jin Zhu, Qiubo Yu, Youde Cao, JingXian Wu, Jing Zeng, Gehong Dong,Wanming Hu (Corresponding Author). Pediatric central nervous system tumor with CIC::LEUTX fusion: a diagnostic challenge. Acta Neuropathologica Communications, 2024, 12(1): 106.

2.Wan-Ming Hu (First Author), Hao Duan, Sheng Zhong, Jing Zeng, Yonggao Mou. High frequency of PDGFRA and MUC family gene mutations in diffuse hemispheric glioma, H3 G34-mutant: a glimmer of hope? Journal of Translational Medicine, 2022, 20(1): 64.

3.Wanming Hu (First Author), Depei Li, Yuanzhong Yang, Yongqiang Zheng, Jing Zeng, Ke Sai. TIM-3/CD68 double-high expression in Glioma: Prognostic characteristics and potential therapeutic approaches. International Immunopharmacology, 2024, 139: 112665.

4. Wen-Zhuo He, Yuan-Zhong Yang, Chen-Xi Yin, Xin-Yi Xian, Jia-Mei Gu, Jia-Hong Yi, Ju Xue, Yue Zhao, Fang Wang,Wan-Ming Hu (Co-corresponding Author) and Liang-Ping Xia. Evolution of HER2-low expression from primary to paired metastatic gastric cancer lesions. NPJ Precision Oncology, 2025, 9(1): 108.

5. Wen-Zhuo He,Wan-Ming Hu (Co-first Author), Fang Wang, Yu-Ming Rong, Lin Yang, Qian-Kun Xie, Yuan-Zhong Yang, Chang Jiang, Hui-Juan Qiu, Jia-Bin Lu, Bei Zhang, Pei-Rong Ding, Xiao-Jun Xia, Jian-Yong Shao, and Liang-Ping Xia. Comparison of mismatch repair status between primary and matched metastatic sites in patients with colorectal cancer. Journal of the National Comprehensive Cancer Network, 2019, 17(10): 1174-1183.